FDA Inspection 1064409 — Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd
The FDA completed an inspection of Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd on August 23, 2018 in Hangzhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- August 23, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Hangzhou (China)